United Therapeutics Competitors and Similar CompaniesClear all

United Therapeutics's competitors and similar companies include Lannett, Immunovative Therapies, tella and Achieve Life Sciences.

	United Therapeutics United Therapeutics is a biotechnology company that develops and manufactures pharmaceutical products for pulmonary arterial hypertension and certain cancers.	Lannett Lannett is a company that specializes in pharmaceutical product families.	Immunovative Therapies Immunovative Therapies is a clinical stage biopharmaceutical company that develops immunotherapy products to treat cancer and infectious diseases.	tella tella is a company that focuses on the research and development of regenerative and cellular medicine, including dendritic cell vaccine therapy.	Achieve Life Sciences Achieve Life Sciences is a biopharmaceutical company that develops and commercializes therapies that address treatment resistance in cancer patients.
Founding Date	Founding Date 1996	Founding Date 1942	Founding Date 2004	Founding Date 2004	Founding Date 1995
Type	Type Public	Type Subsidiary	Type Private	Type Public	Type Public
Tags	Tags Healthcare biotech drug development oncology pharma therapy	Tags Healthcare biotech drug development pharma	Tags Healthcare biotech drug development life sciences oncology pharma therapy	Tags Healthcare biotech drug development life sciences oncology pharma therapy	Tags Healthcare biotech drug development life sciences oncology pharma therapy
Locations	Locations Silver Spring, US HQ Durham, US Jacksonville, US Manchester, US Melbourne, US Washington, US	Locations Trevose, US HQ Philadelphia, US Seymour, US	Locations Jerusalem, IL HQ	Locations HQ	Locations Seattle, US HQ Vancouver, CA Bothell, US Bothell, US
Employees	Employees 1,16819% increase	Employees 484	Employees 6	Employees 35	Employees 148% increase
Valuation ($)	Valuation ($) 15.7 b	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 166.2 m
Financial
Revenue (est.)	Revenue (est.) $3.2b (FY, 2025)	Revenue (est.) $340.6m (FY, 2022)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $384.4m (FY, 2025)	Cost of goods $294.5m (FY, 2022)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $2.8b (FY, 2025)	Gross profit $33.2m (FY, 2022)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income $1.3b (FY, 2025)	Net income ($231.6m) (FY, 2022)	Net income N/A	Net income N/A	Net income ($54.6m) (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 28m	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 10m